Menu
Dear Editor: There is no doubt now that the use of botulinum toxin (BoNT) in aesthetics has been a revolution for the noninvasive treatment of patients. In the last several decades, the use of BoNT has changed from fixed doses delivered at fixed time intervals into fixed anatomical sites, all of which were required for
J Clin Aesthet Dermatol. 2021;14(1):30–33. by Steffen Giesse, MD Dr. Giesse is with the Aesthetic Lounge GmbH, Ludwigshafen in Rhein, Germany FUNDING: No funding was provided for this study. DISCLOSURES: Dr. Giesse is a speaker for BTL Industries Inc. ABSTRACT: Objective. This study evaluated the efficacy of a novel treatment method utilizing high-intensity focused electromagnetic
J Clin Aesthet Dermatol. 2020;13(12):E56–E83 by Mark Nestor, MD, PhD; Joel L. Cohen, MD; Marina Landau, MD; Said Hilton, MD; Andreas Nikolis, MD; Syed Haq, MBBS, PhD; Maurizio Viel, MD; Bill Andriopoulos, PhD; Inna Prygova, MD; Keith Foster, PhD; Alessio Redaelli, MD; and Philippe Picaut, PharmD, PhD Dr. Nestor is with the Miller School of
J Clin Aesthet Dermatol. 2020;13(11):13–18 by Monica Boen, MD; Marwan Alhaddad, MD; Douglas C. Wu, MD, PhD;and Mitchel P. Goldman, MD All authors are with the Cosmetic Laser Dermatology in San Diego, California. FUNDING: This study was funded by Topix Pharmaceuticals Inc. DISCLOSURES: The authors have no conflicts of interest relevant to the content of
J Clin Aesthet Dermatol. 2020;13(11):37–43 by Zoya Diwan, MBBS, BSc, PG Dip Clinical Dermatology; Sanjay Trikha, MBBS, BSc; Sepideh Etemad-Shahidi, BDS, BSc, RCS Eng; Surbhi Virmani, MBBS, MD, PG Dip Dermatology, GDL, LPC, LLB; Catherine Denning, MBBS, MRCS, BSc; Yusra Al-Mukhtar, BDS, BSc, MFDS, RCS Ed, MJDF RCS Eng; Christopher Rennie, MBBCh, MRCS; Amanda Penny,
